Investment Analysts’ Updated EPS Estimates for November 14th (ABUS, BEEP, BN, CADL, CDTX, CHE.UN, CTSO, FRP, LAND, MGA)

Investment Analysts’ updated eps estimates for Friday, November 14th:

Arbutus Biopharma (NASDAQ:ABUS) had its buy rating reaffirmed by analysts at Chardan Capital. They currently have a $5.00 price target on the stock.

Mobile Infrastructure (NASDAQ:BEEP) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $6.50 price target on the stock.

Brookfield (NYSE:BN) had its target price raised by TD Securities from $57.00 to $59.00. They currently have a buy rating on the stock.

Candel Therapeutics (NASDAQ:CADL) had its target price lowered by Citigroup Inc. from $25.00 to $24.00. The firm currently has a buy rating on the stock.

Cidara Therapeutics (NASDAQ:CDTX) had its hold rating reissued by analysts at Needham & Company LLC.

Chemtrade Logistics Income Fund (TSE:CHE.UN) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating. They currently have C$17.00 price target on the stock, up from their previous price target of C$15.00.

Cytosorbents (NASDAQ:CTSO) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $10.00 target price on the stock.

FRP Advisory Group (LON:FRP) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 220 target price on the stock.

Land Securities Group (LON:LAND) had its hold rating reaffirmed by analysts at Shore Capital.

Magna International (NYSE:MGA) (TSE:MG) had its target price increased by Citigroup Inc. from $49.00 to $55.00. Citigroup Inc. currently has a neutral rating on the stock.

Merit Medical Systems (NASDAQ:MMSI) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $106.00 target price on the stock.

NiCE (NASDAQ:NICE) had its price target increased by Citigroup Inc. from $209.00 to $211.00. Citigroup Inc. currently has a buy rating on the stock.

NET Power (NYSE:NPWR) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating.

Omeros (NASDAQ:OMER) had its buy rating reissued by analysts at D. Boral Capital. They currently have a $36.00 price target on the stock.

Research Solutions (NASDAQ:RSSS) had its buy rating reiterated by analysts at Roth Capital. They currently have a $5.00 price target on the stock.

Target (NYSE:TGT) had its market perform rating reissued by analysts at Telsey Advisory Group. They currently have a $110.00 price target on the stock.

Trevi Therapeutics (NASDAQ:TRVI) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $19.00 price target on the stock.

Wabtec (NYSE:WAB) had its target price increased by Citigroup Inc. from $225.00 to $245.00. They currently have a buy rating on the stock.

Warner Bros. Discovery (NASDAQ:WBD) had its outperform rating reissued by analysts at Barrington Research. They currently have a $25.00 price target on the stock.

Walmart (NYSE:WMT) had its outperform rating reiterated by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $118.00 price target on the stock.

Williams-Sonoma (NYSE:WSM) had its target price raised by Telsey Advisory Group from $215.00 to $225.00. They currently have an outperform rating on the stock.

Zura Bio (NASDAQ:ZURA) had its buy rating reissued by analysts at Chardan Capital. The firm currently has a $10.00 target price on the stock.